Please login to the form below

Not currently logged in
Email:
Password:

AZ to sell Astra Tech for $1.8bn

AstraZeneca is to sell Sweden-based dental and devices business Astra Tech to Dentsply for $1.8bn

AstraZeneca (AZ) is to sell Sweden-based dental and devices business Astra Tech to Dentsply for $1.8bn.

Dentsply, a US-based dental equipment maker, is anticipated to complete the acquisition in the second half of 2011.

Astra Tech consists of a dental division, focusing on the research, development, manufacturing and marketing of dental implants; and a healthcare division, focusing on medical devices for use primarily in urology and surgery.

Worldwide revenue for Astra Tech was recorded as $535m for 2010.

"Following a comprehensive strategic review, we believe this transaction represents an excellent outcome for AstraZeneca shareholders," said David Brennan, CEO, AZ. "The high degree of interest and the competitive nature of this process is evidence of the value that the employees of Astra Tech have built in the marketplace."

22nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics